Examines anti-pigmentation effects in melanoma cells, suggesting new natural treatments.
Background/Objectives: Persicaria senticosa (Meisn.) H.Gross (PS) has anti-photoaging, anti-inflammatory, and antioxidant activities, but the anti-pigmentation potential of the PS flower absolute (PSFAb) remains largely unexplored. This study aimed to examine the chemical composition and anti-melanogenic and melanosome transport-inhibitory effects of PSFAb using B16BL6 murine melanoma cells. Methods: PSFAb was extracted with hexane and analyzed by gas chromatography–mass spectrometry (GC-MS). The biological activities in B16BL6 murine melanoma cells were evaluated using water-soluble tetrazolium salt (WST) assays, 5-bromo-2′-deoxyuridine (BrdU) incorporation, enzyme-linked immunosorbent assays, and immunoblotting methods. Results: GC-MS analysis identified eight constituents in PSFAb. Cell viability was not significantly altered in B16BL6 cells at concentrations ≤ 100 μg/mL, which were used for additional tests. PSFAb inhibited serum-induced cell proliferation and suppressed α-melanocyte-stimulating hormone (α-MSH)-induced melanin synthesis and tyrosinase activity in B16BL6 cells. PSFAb also downregulated the α-MSH-induced expression of key melanogenic regulators, including microphthalmia-associated transcription factor (MITF), tyrosinase, tyrosinase-related protein-1 (TRP-1), and TRP-2. PSFAb decreased extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase phosphorylation but enhanced JNK phosphorylation in α-MSH-stimulated B16BL6 cells. Furthermore, PSFAb reduced the α-MSH-induced expression of melanosome transport-related proteins (melanophilin and Rab27a) in B16BL6 cells. Conclusions: Overall, these results suggest that PSFAb has the potential to exert anti-pigmentation effects by suppressing melanogenesis and downregulating melanosome transport-related proteins. Therefore, PSFAb may be a promising candidate for the development of natural agents targeting hyperpigmentation and skin pigmentation regulation.
No takes yet. Share an insight, caveat, or question.
Won et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: